Genomic instability pathways in colorectal cancer (CRC) have been extensively studied, but the role of retrotransposition in colorectal carcinogenesis remains poorly understood.
INTRODUCTION
Retrotransposons are transposable genetic sequences that copy themselves into an RNA intermediate and insert elsewhere in the genome. Almost half of the human genome consists of transposon derived sequences 1 , however only a few elements remain retrotransposition competent and account for most retrotranspositions 2, 3 . Two types of retrotransposons have been identified in the human genome; autonomous and non-autonomous. Autonomous elements, such as Long Interspersed Nuclear Element-1s (LINE-1s) and Endogenous retroviruses (ERVs), provide the required machinery for retrotransposition. On the contrary, non-autonomous elements, such as Alus and SINE-VNTR-Alu (SVAs), require the LINE-1 machinery to retrotranspose [4] [5] [6] [7] . In cancer, approximately 24% of somatic retrotranspositions involve 3´transduction, a process characterized by mobilization of 3´flanking sequence which can serve as a unique sequence revealing the insertion origin [8] [9] [10] [11] . LINE-1s are frequently repressed by promoter methylation 12 and genome-wide hypomethylation is reported to lead to their activation during tumorigenesis 13, 14 , thus leading to high retrotransposon activity and genome instability 15, 16 . High retrotransposon activity has been reported in several human cancers, especially in tumors arising from the gastrointestinal tract, such as colorectal cancer (CRC) 10, 11, [17] [18] [19] [20] . Somatic insertion density in tumors is higher in closed chromatin and late replicating regions. Among insertions in genes, insertion density is higher in genes with low expression 10, 21 . Furthermore, ongoing retrotransposon activity has been reported in CRC 22 . Insertion count is associated with patient age 18 and LINE-1 hypomethylation is associated with poor survival in colorectal cancer 23 .
LINE-1 insertions in APC have been reported in two CRCs, indicating that these insertions may be early tumorigenic events 24, 25 .
1 CRC can develop through two distinct pathways; chromosomal instability (CIN) or microsatellite instability (MSI) . Most sporadic CRCs follow the CIN pathway, characterized by a large number of chromosomal alterations. Fifteen percent of CRC cases follow the MSI pathway, characterized by a high number of base substitutions and short insertions and deletions 26 . Seventy-five percent of MSI-positive sporadic CRCs are attributed to the CpG island methylator phenotype (CIMP) 27 which is characterized by gene promoter hypermethylation. Although genomic instability pathways have been studied extensively in CRC, the tumorigenic role of retrotransposition is not fully understood. Retrotransposon insertions have been difficult to detect with previous methodological approaches and very few genome-wide studies have been reported. Here, we characterized somatic retrotransposon insertions in 201 colorectal cancers and one colorectal adenoma utilizing whole genome sequencing (WGS), and investigated the associations between somatic retrotransposon activity and clinical characteristics.
RESULTS

Genome-wide detection of somatic retrotransposition in colorectal tumors
To characterize the landscape of somatic retrotransposon insertions in CRC we applied 1b ). Each point represents insertion density in the corresponding category for each of the 202 tumors.
Retrotransposon insertions are initiating events in approximately 1% of colorectal tumors
To characterize retrotransposon insertions in genes, all protein-coding transcripts and the insertion polyA/T in conjunction with gene orientation were used to assess insertion orientation. Of the 5,072 insertions, 1,680 (33%) were detected within protein-coding genes, with 98% in introns ( Supplementary Table S1 , Supplementary Figure S1 ). We identified 399 insertions in sense orientation and 472 in antisense orientation, suggesting antisense preference (Exact Binomial Test 95% CI, 50.8-57.3%, p=0.014) ( Supplementary Table S1 ).
Insertion count was higher in genes with lower expression (median transcript per million reads [TPM] from 34 tumors) in concordance with a previous study 21 ( Figure 2a ). Recurrent insertions (at least two insertions) were identified in 333 protein-coding genes
( Supplementary Table S2 ). The most enriched biological processes among these genes were neuron-neuron synaptic transmission and cell-cell adhesion ( Figure 2b ). Fifteen genes in the Cancer Gene Census (CGC) 29 displayed recurrent insertions ( Table 1 ). 4 The most frequently affected protein-coding gene was LRP1B with 19 insertions, all located in introns. LRP1B is a known fragile site 30 and has been classified as a tumor suppressor gene in the CGC. No clear bias towards tumor suppressor genes or oncogenes was apparent among the recurrent targets ( Table 1 ). We also investigated whether insertions had an overall effect on the expression of the closest genes but no significant effect was detected ( Supplementary Figure S2 , Methods section "Association test between insertions and RNA expression" ). Seventy-two insertions were identified in the exons of protein-coding genes ( Supplementary   Table S1 , Supplementary Figure S1 ). We identified one insertion in the last exon/3´UTR of
PIK3CA
( Supplementary Table S1 ) and two insertions in exon 16 of APC ( Figure 3 , Supplementary Table S1 ). Loss of heterozygosity and copy number loss encompassing APC were found in both tumors, and no other sequence variations were identified. Moreover, both insertions were in close proximity (2,151 bp) to two previously reported insertions 31, 32 and the location of the insertions was consistent with the distribution of non-synonymous point mutations detected in APC ( Figure 3 ). Altogether, these findings suggest that retrotransposon insertions contributed to the early steps of tumorigenesis in 2 of the 202 colorectal tumor patients.
Figure 3. Distribution of non-synonymous changes and LINE-1 insertions on the linear protein of APC .
Non-synonymous changes in 187 MSS CRCs, small lollipops . LINE-1 insertions, larger lollipops. p.N809L1
(c1049-1T) and p.P1526L1 (c310.1T), turquoise lollipops; p.F1396L1 and p.P1526L1 31, 32 , black lollipops.
Figure modified from cBio cancer genomics portal 33, 34 .
Recurrent insertions in lowly expressed chromosomal fragile sites
We observed recurrent insertions in 12 out of 21 fragile sites 30 ( Supplementary Table S3 ).
Since common fragile sites are prone to copy number alterations (CNAs) 35 , we evaluated whether retrotransposition and CNAs -in this study detected as allelic imbalances (AI) -were correlated ( Supplementary Table S3 ). Fragile sites with high frequency of insertions seemed to display lower frequency of allelic imbalances ( Figure 4a ). Next, we investigated whether this difference could result from differences in gene expression within fragile sites. Indeed, insertion frequency seemed to be higher in genes with lower expression (Exact Two-Sample
Fisher-Pitman Permutation Test for log-transformed gene expression, p=0.03863) ( Figure   4b ). These results are concordant with our data and those of another study 21 ; insertion density is overall negatively correlated with gene expression. Table S3 ).
Few active LINE-1s account for the majority of LINE-1 transductions
We utilized the 3´unique sequence from the transduced regions to identify the source elements of LINE-1 transductions. We detected a total of 347 transductions arising from 56 of 315 human specific full-length LINE-1s. Recurrent transductions were detected from 24 LINE-1s, and in concordance with our previous study 11 the most active was the LINE-1 located in 22q12.1, which alone accounted for 160 transductions (46%). Seven and six percent of the transductions arose from the LINE-1s located in 9q32 and Xp22.2, respectively. The active LINE-1s reported in this study are in concordance with the frequencies reported by another study across 31 different tumor subtypes ( Supplementary   Table S4 ) 21 .
Insertion count is significantly associated with CIMP and the genomic fraction of allelic imbalance
We investigated the associations between insertion counts and molecular and clinical characteristics. We utilized 196 colorectal tumors with complete information on molecular and clinical variables that were included in the model ( Table 2 , Supplementary Table S5 ).
We applied a multiple linear regression model for log-transformed insertion counts, and hypothesized that the number of somatic insertions may be associated with tumor location, TP53 mutation, MSI, genomic fraction of allelic imbalance and CIMP. The model was adjusted for mean sequencing coverage, tumor stage, sex and age at diagnosis ( Table 2 ).
Goodness-of-fit was tested by Pearson's chi-square test (p=0.99). We found that insertion count was positively associated with CIMP (p=0.00032) and the genomic fraction of allelic imbalance (p=0.0036) ( Table 2 ). 
Insertion count is significantly associated with poor disease-specific survival
We applied the Cox proportional hazards model in 192 patients with complete information on molecular and clinical variables that were used in the model ( Table 3 , Supplementary Table   S5 ). Patients were followed for 1,370 person-years ( Supplementary Table S5 ). We hypothesized that insertion counts may be associated with disease-specific survival ( Figure   5 ). The model was adjusted for tumor stage, sex, MSI, the genomic fraction of allelic imbalance, BRAF mutation and CIMP status ( Table 3 ). As expected, advanced tumor stage (Dukes C and D) was strongly associated with CRC-specific survival. However, even after adjusting for the above-mentioned covariables, insertion count was independently associated with poor disease-specific survival (p=0.0029) ( Figure 5 , Table 3 ). 
DISCUSSION
Although retrotransposon activity is a hallmark of tumors of the gastrointestinal tract 10, 11, [17] [18] [19] [20] , the role of retrotransposon insertions in CRC remains unclear with very few studies reported.
Here, we characterized the somatic landscape of retrotransposon insertions in the largest dataset of colorectal tumor whole-genomes reported to date, and identified significant associations with clinical characteristics.
We observed high retrotransposon activity with wide variability among tumors. We confirmed higher insertion density in late replicating regions, closed chromatin. Among insertions in genes, we also observed higher insertion count in genes with lower expression.
T he list of the most active LINE-1 s became also validated in this extended set of CRCs 10, 11, 21 .
A number of novel observations were made. We identified recurrent insertions in 333 protein-coding genes, 15 of which are included in the Cancer Gene Census 29 . The most recurrent hit was LRP1B with 19 intronic insertions. The high frequency of insertions in this gene could be a result of various characteristics such as chromatin state, replication timing as well as gene length and/or expression. However, other causes such as sequence composition or somatic selection cannot be excluded. We also observed a high frequency of insertions at fragile sites with lower gene expression and lower allelic imbalance fraction. These findings suggest that while allelic imbalance is a recurrent feature of some fragile sites, sites with lower gene expression are more prone to retrotransposon insertions in CRC.
Among the exonic insertions, we identified one in PIK3CA and two in APC . PIK3CA is a known oncogene involved in colorectal tumor progression and mutations in APC lead to colorectal tumor initiation 36 . The insertions in APC were consistent with the distribution of non-synonymous changes in this gene and two previously reported insertions 31, 32 , indicating that retrotransposon insertion in APC is one mechanism of CRC initiation.
The availability of patient data allowed us to investigate possible associations between somatic insertion count and various molecular and clinical characteristics. We applied a multiple linear regression model and found that retrotransposon activity was positively associated with the genomic fraction of allelic imbalance, and paradoxically with CIMP even though LINE-1s are frequently repressed by promoter methylation 12 . Of note, both CIMP and the genomic fraction of allelic imbalance are characteristic of the two distinct genetic instability pathways in CRC. No associations with age at diagnosis, TP53 mutations or tumor stage were detected in contrast to other studies 18, 37 . These studies had significantly smaller sample sizes and fewer covariables were taken into account, which may explain the discrepancy. Importantly, survival analysis revealed a significant association between insertion count and poor disease-specific survival independently of other prognostic factors.
Our findings indicate that tumors with high retrotransposon activity present characteristics of both MSS and MSI tumors, and are associated with poor CRC-specific survival.
By characterizing the landscape of retrotransposon insertions in a large dataset of CRCs, we identified that retrotranspositions can serve as tumor initiating events in CRC. The association of retrotransposition events with clinical characteristics -in particular poor prognosis -suggest that retrotransposition may play a more important role in CRC than previously thought. Further work should elucidate the timing and mechanisms leading to high somatic retrotransposition activity in some individuals, while others are spared.
Understanding these could provide new tools for management of CRC, including prevention.
METHODS
Study subjects
The samples and the clinical data utilized in this study were obtained from a population based series of 1042 CRCs described previously 38, 39 Health was obtained for all the samples.
Whole genome sequencing
Whole genome sequencing was performed on Illumina HiSeq 2000 with 100 bp paired-end reads. Each normal and tumor DNA was sequenced to at least 40x median coverage as described in previous studies 40 (Palin K et al., Nature Communications, 2018, in press).
Transposon detection
The identification of somatic retrotransposon insertions was conducted utilizing the Transposon Finder in Cancer (TraFiC) 10 . TraFiC default parameters were applied except for; a=1 (RepeatMasker accuracy), s=3 (minimum of 3 reads in tumor cluster), and gm=3 (minimum of 3 reads in normal cluster). In addition, paired-end reads with both ends having equal mapping quality and above 0 were included. In these cases, the first end of the pair was selected as the anchor read (end mapping to non-repetitive sequence Genomes Project Phase 2 (hs37d5) 45 were filtered away.
Detection of LINE-1 transductions
We identified 3' and orphan transductions utilizing DELLY structural variant (SV) calls (v 0.0.9) 28 from a previous study 40 . Filtering criteria utilized in this study were: SV calls supported by at least three supporting discordant reads, mapping quality >37, SV length 
Allelic imbalance
The allelic imbalance calls derived from a separate study (Palin K et al., Nature
Communications, 2018, in press). In brief, both the tumor and respective normal DNA were genotyped with Infinium Omni2.5-8 (Illumina Inc.) array at the Estonian Genome Center.
The B-Allele Frequencies and Log-R ratios were extracted with Illumina GenomeStudio 14 software and the allelic imbalance regions were calculated for all samples using BAF segmentation 47 with default parameters.
Methylation-Specific Multiplex Ligation-dependent Probe Amplification (MS-MLPA)
An MS-MLPA assay (Nygren AO, 2005) 
RNA sequencing
Total RNA from consecutive cryosections was extracted using RNeasy Mini Kit (Qiagen) from 34 tumors that displayed more than 50% of cancer cell percentage (HE staining of cryosections) and RNA integrity>6 (Agilent RNA 6000, Agilent 2100 Bioanalyzer).
RNA-seq data was processed using Kallisto (version 0.43.0) software 49 . Kallisto quantification was executed in paired-end mode and aligned against the Ensembl Human reference transcriptome ( GRCh37_79 ). Quantification results from Kallisto were normalized and aggregated to gene-level utilizing sleuth (version 0.28.1) R package 50 with default filtering settings 50 .
Visual inspection of paired-end read data
We selected 100 random insertions to ascertain the rate of true somatic calls based on visual inspection of the paired-end read data. Visualization was performed with BasePlayer 51 .
Somatic calls were visually validated as true if the insertion call was supported by discordant reads (three+three for TraFiC calls) and at least two split reads supporting the insertion breakpoint and/or the polyA/T. Furthermore, the corresponding normal tissue was also visualized to confirm the somatic origin of the insertion calls.
Insertion annotation
Annotation of the insertion calls was applied by using the inner genomic coordinates of the reciprocal clusters provided by TraFiC (P_R_POS & N_L_POS) ( Supplementary Table   S1 ). Insertion breakpoints hitting an intron or an exon of any protein-coding transcript (GRCh37_87) were annotated as intron/exon hit. Insertion orientation was determined by the presence of a polyA or a polyT in conjunction with gene orientation. To call a polyA, at least two forward split reads with at least five consecutive As at the 5´end of the read were required. To call a polyT, at least two reverse split reads with at least 5 consecutive Ts at the 3´end of the read were required. Sense insertions were defined when insertion orientation and gene orientation were the same whereas antisense insertions were defined when insertion and gene orientation were the opposite. Replication time fractions were extracted from another study 52 . Insertion density was defined as number of insertions divided by the total number of base pairs of each replication time fraction. Open chromatin was defined as DNAse regions that were overlapping in at least two out of the four cell lines (RKO, LoVo, CaCo2 and Gp5D) (GSE83968) 53 in the 1000 Genomes Project PilotMask reference genome 54 . Closed chromatin regions were defined as the above-mentioned reference genome minus the open chromatin regions.
Gene ontology analysis
Gene ontology enrichment analysis was performed with PANTHER Overrepresentation Test (Released 20171205), annotation version 13.1 released 2018-02-03 and the test utilized was
Fisher's exact test with FDR multiple test correction 55 .
Fragile sites
The 21 fragile sites were defined as genes with more than 0.85 probability of being fragile (Random forest 3 predictors) as estimated in another study 30 with default parameters (GRCh37_78), as described in a previous study 40 
Association test between insertions and RNA expression
For the 827 insertions identified in any of the 34 tumors, we investigated the effect on the expression of the 642 distinct closest genes. For each sample and each gene the TPM values were extracted and ranked in an ascending order. Consequently, the rank number corresponding to the sample with the insertion was recorded for each gene. We computed the Figure S2 ). Furthermore, 100 000 permutations with randomized rank numbers were applied but no significant effect was observed ( Supplementary Figure S2 ). Tests were performed using R versions 3.4.3 or 3.3.0.
Multiple linear regression analysis
To model retrotransposon insertion counts we applied a multiple linear regression model for Figures S3-S5 ). All tests were performed using R version 3.3.2 58 .
Cox proportional hazards regression analysis
We applied the Cox proportional hazards regression to study the association between disease-specific survival with retrotransposon insertion counts. The time variable was defined as days since diagnosis or operation. Patients that were alive in the last status assessment were censored at that date (survival status was assessed periodically using the Population Register Centre of Finland with the most recent assessment in 2016). Death from other causes than CRC were also defined as censored events. Proportional hazards assumptions were assessed by Grambsch-Therneau test for proportional hazards and evaluation for a non-zero slope of the scaled Schoenfeld residuals versus transformed time ( Supplementary Figure   S6 ). Based on inspection of the scaled Schoenfeld residuals, the model was stratified by tumor location. Influential observations were assessed with dfbeta and martingale residuals ( Supplementary Figure S7 and S8 ). All tests were performed using R version 3.3.2 58 .
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